The buying interest on the pharma company's counter came after it launched 'Wanbury C RED', a Liposomal Iron formulation ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 18, 2025 /EINPresswire / -- The Business Research Company's Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market Size in Japan has been assessed to be ~USD 35 million in 2023, expected to ...

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

Anemia commonly occurs in people with HIV. Learn about what causes anemia, how to treat it, and more.

Anemia is usually mild, and a person can typically receive effective treatment. However, some types of anemia are severe and potentially life threatening.

An overview of World Sickle Cell Anemia Day 2025 and the global and local challenges of managing sickle cell disease.

International aid organizations warn that the last remaining major hospital in southern Gaza is facing a lack of supplies and ...

Screening camps will be held across 130 gram panchayats in tribal agency areas to detect and prevent sickle cell anemia.

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...